Westpac Banking Corp’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-27,128
| Closed | -$2.91M | – | 512 |
|
|
2023
Q1 | $2.91M | Sell |
27,128
-9,614
| -26% | -$1.03M | 0.04% | 460 |
|
|
2022
Q4 | $4.49M | Sell |
36,742
-44,858
| -55% | -$5.48M | 0.07% | 353 |
|
|
2022
Q3 | $8.43M | Buy |
81,600
+370
| +0.5% | +$38.2K | 0.13% | 215 |
|
|
2022
Q2 | $7.55M | Buy |
81,230
+2,834
| +4% | +$263K | 0.1% | 283 |
|
|
2022
Q1 | $9.2M | Sell |
78,396
-1,936
| -2% | -$227K | 0.11% | 261 |
|
|
2021
Q4 | $10.8M | Sell |
80,332
-5,763
| -7% | -$775K | 0.11% | 228 |
|
|
2021
Q3 | $13.7M | Buy |
86,095
+12,655
| +17% | +$2.02M | 0.15% | 181 |
|
|
2021
Q2 | $9.66M | Buy |
73,440
+851
| +1% | +$112K | 0.1% | 275 |
|
|
2021
Q1 | $9.36M | Sell |
72,589
-4,938
| -6% | -$636K | 0.1% | 257 |
|
|
2020
Q4 | $12.9M | Sell |
77,527
-2,916
| -4% | -$486K | 0.15% | 172 |
|
|
2020
Q3 | $12.4M | Sell |
80,443
-2,009
| -2% | -$310K | 0.17% | 150 |
|
|
2020
Q2 | $12.2M | Buy |
82,452
+13,420
| +19% | +$1.98M | 0.18% | 146 |
|
|
2020
Q1 | $7.77M | Sell |
69,032
-14,007
| -17% | -$1.58M | 0.13% | 201 |
|
|
2019
Q4 | $11.6M | Buy |
83,039
+200
| +0.2% | +$27.8K | 0.15% | 180 |
|
|
2019
Q3 | $7.98M | Buy |
+82,839
| New | +$7.98M | 0.11% | 260 |
|
|
2019
Q1 | – | Sell |
-87,160
| Closed | -$5.46M | – | 728 |
|
|
2018
Q4 | $5.46M | Buy |
+87,160
| New | +$5.46M | 0.09% | 307 |
|